Veradermics is trading 5.4% up at $116.15 as growth stocks rally following softer-than-expected CPI inflation data.
- The move marks a rebound from sharp declines on July 10 and July 13, which were triggered by prior sector-wide and geopolitical pressures.
- There are no fresh company-specific news or regulatory filings today; the price action appears driven by broader market sentiment rather than a new internal development.
- The stock is benefiting from an increased risk appetite and a general bid into growth-oriented equities following the inflation report.